Search
for
Sort by
Research 181–210 of 1000+
- Relationship Between Male Pattern Baldness and the Risk of Aggressive Prostate Cancer: An Analysis of the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
- Risk of Depression after 5 Alpha Reductase Inhibitor Medication: Meta-Analysis
- Advances in Knowledge of Androgens: How Intentional and Accidental Neurosteroid Changes Inform Us of Their Action and Role
- One year cross-sectional study of association between androgenetic alopecia and benign prostatic hyperplasia in a tertiary care hospital
- Safety and Efficacy Assessment of Red Ginseng Oil (RXGIN) in Men with Lower Urinary Tract Symptoms in a Randomized, Double-Blind, Placebo-Controlled Trial
- Scientific Evaluation of A Unani Pharmacopoeia-Based Formulation on BPH in Animal Model
- 술 전 5-알파환원효소억제제의 투여가 120W Greenlight TM HPS 레이저를 이용한 광선택적 전립선기화술에 미치는 영향
- Effects of 5-?±-Reductase Inhibitor (Finasteride) on Per Operative Blood Loss in Patients with BPH undergoing TURP
- Hétérogénéité tumorale du cancer de la prostate et infection par le SARS-CoV2 : une relation complexe impliquant les vésicules extracellulaires et le récepteur des androgènes
- Association between degrees of alopecia and prostate specific antigen level in men with androgenetic alopecia
- Sex differences in SARS-CoV-2 infection rates and the potential link to prostate cancer
- THERAPEUTIC HOTLINE: Treatment of androgenic alopecia with finasteride may result in a high grade prostate cancer in patients: fact or fiction?
- Spermatogenic and Androgenic Potential of Nephrolepis biserrata on Testosterone- Propionate Induced Benign Prostatic Hyperplasia In Male Wistar Rats
- Why are men with premature alopecia at higher risk of benign prostatic hyperplasia? And what about prostate cancer?
- 5α-Reductase type 2 gene variant associations with prostate cancer risk, circulating hormone levels and androgenetic alopecia
- The Risks and Benefits of 5α-Reductase Inhibitors for Prostate-Cancer Prevention
- The E211 G>A Androgen Receptor Polymorphism Is Associated with a Decreased Risk of Metastatic Prostate Cancer and Androgenetic Alopecia
- Male pattern baldness and the risk of prostate cancer
- Adverse health effects of androgen use
- Association between male pattern baldness and prostate disease: A meta-analysis
- Hormonal treatment for male-pattern hair loss: implications for cancer of the prostate?
- Dutasteride: A Review of its Use in the Management of Prostate Disorders
- An Overview of Chemotherapy Side Effects on Patients with Prostate Cancer, Bladder Cancer, and Testicular Cancer at Haji Adam Malik General Hospital Medan from 2020-2022
- From Anti-Aging Medicine to Precision Healthspan Pharmacology: Evidence Domains, Monitoring Requirements, and Practical Boundaries
- The Role of Androgens in Health and Disease in Females: A Narratıve Review
- Potential Health Risks Associated with Cosmetics and Personal Care Products: An Overview
- Causal associations between plasma proteins and prostate cancer: a Proteome-Wide Mendelian Randomization
- Re: Associations Between Variants in the Cyclooxygenase 2 Enzyme Gene (PTGS2) and Development of Benign Prostate Enlargement
- Are PSA adjustments necessary for prostate cancer screening in men taking finasteride for hair loss?
- Prostate Specific Antigen as Predictive Factor for Androgenemia in Women